Insider Trading & Ownership - Sussman Joel F.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Sussman Joel F.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-11-12
Sale
2020-11-16
7:46 pm
Galera Therapeutics Inc.GRTXSussman Joel F.
Chief Accounting Officer
20,000$10.19$203,82435,844
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-01-26
Option Award
2021-01-28
4:05 pm
N/A
2031-01-25
Galera Therapeutics Inc.GRTXSussman Joel F.
Chief Accounting Officer
50,000$050,000
(Direct)
View
2020-11-12
Exercise
2020-11-16
7:46 pm
N/A
N/A
Galera Therapeutics Inc.GRTXSussman Joel F.
Chief Accounting Officer
13,606$1.0735,844
(Direct)
View
2020-11-13
Exercise
2020-11-16
7:46 pm
N/A
N/A
Galera Therapeutics Inc.GRTXSussman Joel F.
Chief Accounting Officer
3,755$1.1435,844
(Direct)
View
2020-11-13
Exercise
2020-11-16
7:46 pm
N/A
N/A
Galera Therapeutics Inc.GRTXSussman Joel F.
Chief Accounting Officer
2,639$2.4335,844
(Direct)
View
2020-11-12
Exercise
2020-11-16
7:46 pm
N/A
2023-01-22
Galera Therapeutics Inc.GRTXSussman Joel F.
Chief Accounting Officer
20,000$035,844
(Direct)
View
2020-01-31
Option Award
2020-02-04
6:05 pm
N/A
2030-01-30
Galera Therapeutics Inc.GRTXSussman Joel F.
Chief Accounting Officer
49,263$049,623
(Direct)
View

Ownership
2019-11-06
5:19 pm
N/A
2023-01-22
Galera Therapeutics Inc.GRTXSussman Joel F.
Chief Accounting Officer
0$0114,754
(Direct)
View